Celldex (NASDAQ: CLDX) reported Q4 EPS of ($0.33), $0.02 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $1.8 million versus the consensus estimate of $640 thousand.

For earnings history and earnings-related data on Celldex (CLDX) click here.